"Impact of the ACCP Antithrombotic Guidelines on Potential Utilization of Dabigatran in Patients With Atrial Fibrillation" by Mark Malesker

Presentation

Impact of the ACCP Antithrombotic Guidelines on Potential Utilization of Dabigatran in Patients With Atrial Fibrillation

Chest (2013)

Mark Malesker, Creighton University
Dayla Boldt
Hua Ling
Tammy Burns
Daniel Hilleman

Link

Disciplines

Critical Care,
Cardiology,
Internal Medicine and
Medicine and Health Sciences

Publication Date

October 1, 2013

DOI

10.1378/chest.1701939

Citation Information

Mark Malesker, Dayla Boldt, Hua Ling, Tammy Burns, et al.. "Impact of the ACCP Antithrombotic Guidelines on Potential Utilization of Dabigatran in Patients With Atrial Fibrillation" Chest (2013)
Available at: http://works.bepress.com/hua-ling/15/